4
Changes in Ownership
ORAMED PHARMACEUTICALS INC. Filed Acc 0001213900-26-001279
Chief Scientific Officer acquired 236,331 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kidron Miriam Chief Scientific Officer | 2025-12-31 | Grant or award | +121,331 | 1,314,664 | D: show line 1 in the form | ||
| Kidron Miriam Chief Scientific Officer | 2025-12-31 | Grant or award | +115,000 | 1,429,664 | D: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Kidron Miriam Chief Scientific Officer | 2025-12-31 | Grant or award · Performance Stock Units | +19,000 | 19,000 | D: show line 3 in the form |
Loading xslF345X05/ownership.xml…